Comparison of Bariatric Surgery and Glucagon-Like Peptide-1 Analogs for Prevention of Nonalcoholic Fatty Liver Disease in an Obese Population: A Large Multi-Center Study

被引：0
|
作者：
Cohen, Ethan M. [1 ]
Adekolu, Ayowumi A. [1 ]
Maan, Soban A. [1 ]
Foryoung, Joyce [1 ]
Thakkar, Shyam [1 ]
Singh, Shailendra [1 ]
机构：
[1] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1652
引用
收藏
页码：S1237 / S1237
页数：1
相关论文
共 50 条
  • [21] Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure
    Wolff Sagy, Yael
    Lavie, Gil
    Ramot, Noga
    Battat, Erez
    Arbel, Ronen
    Reges, Orna
    Dicker, Dror
    NATURE MEDICINE, 2024, 30 (08) : 2337 - 2342
  • [22] Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
    Mantovani, Alessandro
    Petracca, Graziana
    Beatrice, Giorgia
    Csermely, Alessandro
    Lonardo, Amedeo
    Targher, Giovanni
    METABOLITES, 2021, 11 (02) : 1 - 13
  • [23] The Impact of Preoperative Glucagon-Like Peptide-1 Receptor Agonist Use on Bariatric Surgery Outcomes
    Abuhasan, Qais
    Li, Wendy
    Burney, Charles
    Funk, Luke M.
    Holl, Jane
    Selzer, Don
    Stefanidis, Dimitrios
    Yuce, Tarik
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S34 - S35
  • [24] Preoperative Glucagon-Like Peptide-1 Receptor Agonist Utilization and Association with Bariatric Surgery Outcomes
    Abuhasan, Qais
    Funk, Luke M.
    Holl, Jane L.
    Draucker, Claire
    Grannis, Shaun
    Bilimoria, Karl Y.
    Stefanidis, Dimitrios
    Yuce, Tarik K.
    OBESITY SURGERY, 2025, 35 (02) : 556 - 560
  • [25] Preoperative Weight Loss with Glucagon-Like Peptide-1 Receptor Agonists Before Bariatric Surgery
    Ruhle, Brian
    Bartoletti, Sebastiano
    Hauser, Michelle
    Azagury, Dan E.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S28 - S28
  • [26] Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease
    Lee, Han Ah
    Kim, Hwi Young
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [27] THE EFFECT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ON SUBCUTANEOUS WHITE/BROWN ADIPOSE TISSUE AND NONALCOHOLIC FATTY LIVER DISEASE ACCORDING TO MAGNETIC RESONANCE SPECTROSCOPY IN OBESE PATIENTS
    Kurochkina, Natalia
    Sergienko, Igor
    Ustyuzhanin, Dmitry
    Shariya, Merab
    ATHEROSCLEROSIS, 2024, 395
  • [28] Effect of glucagon-like peptide-1 on glucagon secretion, endogenous glucose production and whole body lipolysis in patients with nonalcoholic liver disease
    Junker, A. E.
    Gluud, L.
    Hall, G. V.
    Holst, J. J.
    Knop, F. K.
    Vilsboll, T.
    DIABETOLOGIA, 2015, 58 : S267 - S267
  • [29] Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation
    Wang, Xing-Chun
    Gusdon, Aaron M.
    Liu, Huan
    Qu, Shen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (40) : 14821 - 14830
  • [30] Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation
    Xing-Chun Wang
    Aaron M Gusdon
    Huan Liu
    Shen Qu
    World Journal of Gastroenterology, 2014, (40) : 14821 - 14830
12345